Related references
Note: Only part of the references are listed.Toll-like receptors in mediating pathogenesis in systemic sclerosis
L. Frasca et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis
Takashi Maehara et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Pathogenesis of heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
TRANSLATIONAL RESEARCH (2020)
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus
R. Lande et al.
SCIENTIFIC REPORTS (2020)
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
Jose Perdomo et al.
NATURE COMMUNICATIONS (2019)
Pathophysiology of systemic sclerosis: current understanding and new insights
Maurizio Cutolo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K. Persson et al.
SCIENCE (2019)
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
Roberto Lande et al.
NATURE COMMUNICATIONS (2019)
Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets
Marc Scherlinger et al.
AUTOIMMUNITY REVIEWS (2018)
Toll Like Receptors in systemic sclerosis: An emerging target
Steven O'Reilly
IMMUNOLOGY LETTERS (2018)
Netting Neutrophils Activate Autoreactive B Cells in Lupus
Nicolas Gestermann et al.
JOURNAL OF IMMUNOLOGY (2018)
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Marie Dominique Ah Kioon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology
Lei Qin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Neutrophil accumulation and NET release contribute to thrombosis in HIT
Kandace Gollomp et al.
JCI INSIGHT (2018)
Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease A pilot study
Lei Ye et al.
MEDICINE (2017)
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia
Douglas B. Cines et al.
BLOOD ADVANCES (2016)
Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria
Sven Brandt et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis
Zhili Niu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder
Theodore E. Warkentin et al.
BLOOD (2014)
Fibrosis-a lethal component of systemic sclerosis
Yuen Yee Ho et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Roberto Lande et al.
NATURE COMMUNICATIONS (2014)
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
The role of type 1 interferon in systemic sclerosis
Minghua Wu et al.
FRONTIERS IN IMMUNOLOGY (2013)
From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
Silvia Bellando-Randone et al.
CURRENT RHEUMATOLOGY REVIEWS (2013)
Role of type I interferons in the activation of autoreactive B cells
Kerstin Kiefer et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus-Prone Mice
Sun-Hee Hwang et al.
JOURNAL OF IMMUNOLOGY (2012)
Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus
Takashi Satoh et al.
RHEUMATOLOGY (2012)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
Roberto Lande et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients
Federica Capolunghi et al.
RHEUMATOLOGY (2010)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PF4/heparin complexes are T cell-dependent antigens
S Suvarna et al.
BLOOD (2005)
High resolution HLA-DRB1 identification of a Caucasian population
F Williams et al.
HUMAN IMMUNOLOGY (2004)
CCL27-CCR10 interactions regulate T cell-mediated skin inflammation
B Homey et al.
NATURE MEDICINE (2002)
Share Paper
